Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on July 7, 2025

Novel Digital Test Provides Revolutionary Tool to Assess Brain Chemistry
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer’s …

Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through Gero's AI-driven human data-first platform Accelerating the creation of innovation by combining Gero's …

Expert’s Presentation Exposes Massive Federal Resource That Could Quietly Fund Trump’s Ambitious New Agenda
Baltimore, MD, July 07, 2025 (GLOBE NEWSWIRE) -- A released presentation by economic strategist Jim Rickards is drawing fresh attention just as President Trump prepares to introduce his most sweeping economic legislation to date—a bill insiders are …

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …

Home Decor Brand Graham & Brown Boosts Operational Efficiency and Growth with BigCommerce
AUSTIN, Texas and LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced that Graham …

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …

A-Mark Precious Metals Announces Quarterly Cash Dividend
EL SEGUNDO, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per …

Monument Announces Commencement of Expansion Drilling Program at Selinsing Gold Mine
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY, FSE: D7Q1) ("Monument" or the "Company") is pleased to announce the commencement of its expansion drilling program at the Selinsing Gold Mine including …

NowVertical Announces 2025 Shareholder Meeting Results and Equity Grants
TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NOW” or the “Company”), a leading data and AI solutions provider, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders held on …

CORRECTION: Press Release Announcing Purchased About US$50 Million BNB
HONG KONG, July 07, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced a correction to the first paragraph of its press release …

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approval Tividenofusp alfa is designed to deliver missing enzyme to entire body and cross blood-brain barrier into the brain Tividenofusp alfa leads company’s broader …

Genius Group increases Bitcoin Treasury target to 10,000 BTC
Plans to finance the Bitcoin purchases via balanced mix of funding sources SINGAPORE, July 07, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today …

From Investment to Real Estate: U.S. Accepts Bitcoin for Home Purchases, and LET Mining Helps Asset Growth
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- As new federal guidelines enable cryptocurrency to qualify as a mortgage asset, U.S. homeowners can now leverage Bitcoin directly in home purchases—with LET Mining poised to support this evolution by …

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35th Annual International Cannabinoid Research Society Symposium SOLANA BEACH, Calif., July 07, …

Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
BRUSSELS, July 07, 2025 (GLOBE NEWSWIRE) -- The need to establish a fund under the EU budget to support the production of critical medicines in Europe is a conclusion drawn from an analysis of the impact of the war on the availability of medicines in …

Textile Recycling Market Projected to Reach $7.26 Billion by 2032, Growing at a 4.9% CAGR Amid Rising Sustainability Initiatives | AnalystView Market Insights
San Francisco, USA, July 07, 2025 (GLOBE NEWSWIRE) -- The global Textile Recycling Market is experiencing a steady transformation as environmental concerns, sustainability goals, and circular economy initiatives reshape industry priorities. Valued at USD 7 …

Centerra Gold Provides Notice of Second Quarter 2025 Results and Conference Call
TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its second quarter 2025 operating and financial results after the market closes on Wednesday August 6, 2025. The Company will …

Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria
8 of 9 participants (89%) treated in the 240mg and 360mg single dose cohorts achieved a complete response 8 of 11 participants (73%) enrolled in the 180mg Q8W open label extension study achieved a complete response at 12 weeks Results from the 240mg Q8W …

Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro …

Almaden Provides Update on Arbitration Procedure with Mexico
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) announces that a public copy of the Memorial document (“Memorial”) that it filed in March of this year regarding its …